Grilinctus-BM Tablet

Introduction

Grilinctus-BM is a medication that combines two active ingredients: Terbutaline and Bromhexine. It is available in tablet form and is primarily used for the treatment of respiratory conditions.

Uses

Grilinctus-BM is commonly prescribed to relieve symptoms associated with respiratory disorders such as asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). It helps to alleviate coughing, wheezing, and shortness of breath, making it easier to breathe.

Dosage and Administration

The dosage of Grilinctus-BM will be determined by your healthcare provider based on your specific condition and medical history. Follow their instructions carefully. In general, the recommended dosage for adults is one tablet taken orally three times a day, with or without food.

Mechanism of Action

Terbutaline, one of the active ingredients in Grilinctus-BM, belongs to a class of medications known as beta-2 adrenergic agonists. It works by relaxing the smooth muscles in the airways, which helps to open up the air passages and improve airflow to the lungs. This makes breathing easier for individuals with respiratory conditions.

Bromhexine, the other active ingredient, is classified as a mucolytic agent. It works by thinning and loosening mucus in the airways, making it easier to cough up and clear the respiratory passages.

Side Effects

Common side effects may include:

• Nausea
• Vomiting
• Headache
• Tremors
• Increased heart rate

These side effects are generally mild and temporary. However, if you experience any severe or persistent side effects, such as chest pain, difficulty breathing, or allergic reactions, seek immediate medical attention.

Drug Interactions

Grilinctus-BM may interact with certain medications, including beta-blockers, monoamine oxidase inhibitors (MAOIs), and other medications that affect heart rate or blood pressure. Inform your healthcare provider about all the medications you are currently taking to avoid potential drug interactions.

Precautions

Before taking Grilinctus-BM, inform your healthcare provider about any existing medical conditions, allergies, or medications you are currently taking. This medication may not be suitable for individuals with certain conditions such as heart disease, high blood pressure, or hyperthyroidism.

Grilinctus-BM should be used with caution in pregnant or breastfeeding women, as the safety of the medication in these populations has not been fully established. It is always recommended to consult with your healthcare provider before starting any new medication during pregnancy or while breastfeeding.

Storage

Grilinctus-BM should be stored at room temperature, away from direct sunlight and moisture. Keep it out of the reach of children and pets. Do not use the medication if it has expired or if the packaging is damaged.

Patient Tips

• Take the medication exactly as prescribed by your healthcare provider.
• Do not exceed the recommended dosage.
• If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• If you have any concerns or questions about the medication, don’t hesitate to consult your healthcare provider or pharmacist.
• attend regular check-ups with your healthcare provider to monitor your progress and assess the effectiveness of the medication.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Bricanyl Injection, 0.5 mg/ml, solution for injection or infusion (Health Professionals SmPC) Available at:
• Bromhexine (International database) (Drugs.com) [Accessed 24 Jun. 2024] (online) Available at:
• terbutaline sulfate (RX) [Accessed 14 Jun. 2024] (online) Available at:
• Terbutaline (MedlinePlus) [Accessed 10 Jun. 2024] (online) Available at:
• Sehgal SK, Mohan M. Bromhexine. Indian Pediatr. 1990 May;27(5):479-83. [Accessed 16 Jun. 2024] Available at: